Buyout (LBO, MBO, MBI) • Consumer Products

ArchiMed Acquires Natural Origins

On September 19, 2016, private equity firm ArchiMed acquired consumer products company Natural Origins

Acquisition Context

This is ArchiMed’s 1st transaction in the Consumer Products sector.
This is ArchiMed’s 1st transaction in France.

Investment Fate

Natural Origins was sold to a strategic buyer in 2017.

Explore All 1131 Buyout (LBO, MBO, MBI) Consumer Products Deals - Search the Database Free

M&A Deal Summary
Date	September 19, 2016
Target	Natural Origins
Sector	Consumer Products
Buyer(s)	ArchiMed
Deal Type	Buyout (LBO, MBO, MBI)

Target Company

Natural Origins

Lozanne, France

Natural Origins is a provider of medicinal plants from the International Pharmacopeia for the nutraceutical and pharmaceutical industries. Natural Origins is able to source, transform and deliver almost all existing medicinal plants in all possible forms to end-product manufacturers. The company has developed a unique expertise in medicinal botany and built direct relationships with suppliers around the world. Natural Origins was founded in 1999 and is based in Lozanne, France.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

ArchiMed

Investor Investor

Category	Private Equity Firm
Founded	2014
PE ASSETS	8.0B EUR
Size	Mega
Type	Sector Focused

DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

Deal Context for Buyer	#
Overall	7 of 38
Sector: Consumer Products	1 of 4
Type: Buyout (LBO, MBO, MBI)	5 of 21
Country: France	1 of 7
Year: 2016	2 of 4

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2016-09-19	Micromed Treviso, Italy Micromed is a medical device company delivering solutions in Neurophysiology to over 78 countries worldwide. Partnering with hospitals, sleep labs, and research centers on a global scale, the company manufactures and markets high-quality, cost-effective, and clinically relevant neurodiagnostic hardware and software to neurologists, clinicians, and researchers for use on adult and pediatric patients. Its product portfolio ranges from Routine, Ambulatory, and Video EEG to electrocorticography (ECoG), stereoelectroencephalography (SEEG), PSG, evoked potentials (EP), EMG and ICU multimodal monitoring solutions for clinical and research. Micromed was formed in 1982 and is based in Treviso, Italy.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2016-09-19

Micromed

Treviso, Italy

Micromed is a medical device company delivering solutions in Neurophysiology to over 78 countries worldwide. Partnering with hospitals, sleep labs, and research centers on a global scale, the company manufactures and markets high-quality, cost-effective, and clinically relevant neurodiagnostic hardware and software to neurologists, clinicians, and researchers for use on adult and pediatric patients. Its product portfolio ranges from Routine, Ambulatory, and Video EEG to electrocorticography (ECoG), stereoelectroencephalography (SEEG), PSG, evoked potentials (EP), EMG and ICU multimodal monitoring solutions for clinical and research. Micromed was formed in 1982 and is based in Treviso, Italy.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2016-09-20	Polyplus Illkirch, France Polyplus is a biotechnology company that supports Gene and Cell therapy, biologics manufacturing, and life science research with innovative nucleic acid transfection solutions. Polyplus was founded in 2001 and is based in Illkirch, France.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2016-09-20

Polyplus

Illkirch, France

Polyplus is a biotechnology company that supports Gene and Cell therapy, biologics manufacturing, and life science research with innovative nucleic acid transfection solutions. Polyplus was founded in 2001 and is based in Illkirch, France.

Buy

Explore Related M&A Activity

Consumer Products M&A - Buyout (LBO, MBO, MBI) M&A Deals - France M&A - 2016 M&A